Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Eric, Low"'
Autor:
Sophie Staniszewska, Ivett Jakab, Eric Low, Jean Mossman, Phil Posner, Don Husereau, Richard Stephens, Michael Drummond
Publikováno v:
Research Involvement and Engagement, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Background Patient and public involvement in health economic evaluation is still relatively rare, compared to other areas of health and social care research. Developing stronger patient and public involvement in health economic evaluation wi
Externí odkaz:
https://doaj.org/article/a2eefb3d99a544cab789fdffa3523172
Autor:
John F.P. Bridges, Esther W. de Bekker-Grob, Brett Hauber, Sebastian Heidenreich, Ellen Janssen, Alice Bast, Janel Hanmer, Andriy Danyliv, Eric Low, Jacoline C. Bouvy, Deborah A. Marshall
Publikováno v:
Value in Health. 26:153-162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f91e32074e82c09708c1b2c4aa19baa
https://doi.org/10.1016/j.jval.2022.12.004
https://doi.org/10.1016/j.jval.2022.12.004
Autor:
Ilaria J Chicca, Jennifer LJ Heaney, Gulnaz Iqbal, Janet A Dunn, Stella Bowcock, Tim Planche, Guy Pratt, Kwee Yong, Eric Low, Jill Wood, Kerry Raynes, Helen Higgins, Mark T Drayson
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 7, Iss 10 (2020)
Background: Multiple myeloma is a cancer of plasma cells that is associated with severe immunodeficiency and increased numbers of bacterial infections. The Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial assessed the use of prophylact
Externí odkaz:
https://doaj.org/article/112110a22ca74a9baedf5fd46e42bff3
Autor:
Rena Yadlapati, Eric Low
Publikováno v:
Alimentary pharmacologytherapeutics. 56(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434b748d5a5a7ba8ec8c767159171ba1
https://pubmed.ncbi.nlm.nih.gov/35751633
https://pubmed.ncbi.nlm.nih.gov/35751633
Autor:
Mark T Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire T Hulme, Anna C Whittaker, Peter Hawkey, Eric Low, Janet A Dunn
Publikováno v:
Health Technology Assessment, Vol 23, Iss 62 (2019)
Background: Myeloma causes profound immunodeficiency and recurrent serious infections. There are approximately 5500 new UK cases of myeloma per annum, and one-quarter of patients will have a serious infection within 3 months of diagnosis. Newly diagn
Externí odkaz:
https://doaj.org/article/392435aa3b8549f6a670a41079277d7d
Autor:
Rena Yadlapati, Eric Low
Publikováno v:
Neurogastroenterology & Motility. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41d15895583d7cf48f5c78d3fb40df30
https://doi.org/10.1111/nmo.14537
https://doi.org/10.1111/nmo.14537
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 11 (2018)
To study characterization of zebrafish glycine receptors (zGlyRs), we assessed expression and function of five α- and two ß-subunit encoding GlyR in zebrafish. Our qPCR analysis revealed variable expression during development, while in situ hybridi
Externí odkaz:
https://doaj.org/article/072f26b6ed2d48569d9cb26d96c783c1
Autor:
Larsen Alessandro, Kat-Jun Eric Low, Aisha Abushelaibi, Swee-Hua Erin Lim, Wan-Hee Cheng, Sook-keng Chang, Kok-Song Lai, Yap Wai Sum, Sathiya Maran
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 14285
The diagnosis of endometrial cancer involves sequential, invasive tests to assess the thickness of the endometrium by a transvaginal ultrasound scan. In 6–33% of cases, endometrial biopsy results in inadequate tissue for a conclusive pathological d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e203325247fc57ecfbec5d4d754aff2
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S31-S32
IntroductionPatient preferences (PPs) are an important source of evidence in health technology assessment (HTA). However, a methodological framework to achieve their integration in decision-making is lacking. We aim to investigate the potential role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b13fcf7a72860c8df3581a1a4592c27
https://doi.org/10.1017/s0266462322001313
https://doi.org/10.1017/s0266462322001313
Autor:
Kerry Raynes, Stella Bowcock, Gulnaz Iqbal, Eric Low, Helen B Higgins, Jennifer L J Heaney, Ilaria J. Chicca, Kwee Yong, Mark T. Drayson, Jill Wood, Janet A. Dunn, Guy Pratt, Tim Planche
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 7, Iss 10 (2020)
Background Multiple myeloma is a cancer of plasma cells that is associated with severe immunodeficiency and increased numbers of bacterial infections. The Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial assessed the use of prophylacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c43a075f27627210fbfcf59ac8b3db
https://doi.org/10.3310/eme07100
https://doi.org/10.3310/eme07100